as on November 6, 2025 at 2:29 am IST
Day's Low
Day's High
5.94%
Downside
1.98%
Upside
52 Week's Low
52 Week's High
67.74%
Downside
49.50%
Upside
Check Oncolytics Biotech Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$113.9M
EPS (TTM)
-0.283
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-30.9M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-249.28%
Compare market cap, revenue, PE, and other key metrics of Oncolytics Biotech Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $113.9M | -56.73% | NA | 0.00% | |
| BUY | $39.0B | 433.32% | -16.34 | -264.83% | |
| BUY | $57.3B | 207.17% | 1446.9 | 1.36% | |
| BUY | $109.2B | 92.12% | 30.3 | 31.86% | |
| BUY | $67.5B | 6.66% | 15.38 | 32.13% |
The Oncolytics Biotech Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Oncolytics Biotech Inc investment value today
Current value as on today
₹90,944
Returns
Returns from Oncolytics Biotech Inc Stock
Dollar Returns*
₹5,351 (+5.35%)
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Oncolytics Biotech Inc. Average target price of $4.57
Get share price movements and forecasts by analysts on Oncolytics Biotech Inc.
What analysts predicted
77.9%UPSIDE
Target Price
$4.57
Current Price
$1.01
Analyzed by
11 Analysts
Target
$4.57
Oncolytics Biotech Inc target price $4.57, a slight upside of 77.9% compared to current price of $1.01. According to 11 analysts rating.
Search interest for Oncolytics Biotech Inc Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 16 September
Tue, 10:00 PM
-Oncolytics expands GOBLET study to U.S., showing promising early efficacy signals in gastrointestinal cancers.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 163.7% return, outperforming this stock by 181.9%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 904.2% return, outperforming this stock by 927.6%
Price Dip
![]()
In the last 7 days, ONCY stock has moved down by -17.5%
| Organisation | Oncolytics Biotech Inc |
| Headquarters | 322 11th Avenue SW, Calgary, AB, Canada, T2R 0C5 |
| Industry | Health Technology |
| CEO | Mr. Jared Kelly J.D., L.L.M. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. John Mark Lievonen B.B.A., CM, F.C.A., FCPA, LLD, M.B.A. | Consultant |
Mr. Kirk J. Look C.A., CPA | Chief Financial Officer |
Dr. Thomas C. Heineman M.D., Ph.D. | Chief Medical Officer |
Ms. Allison Hagerman P.Eng., P.M.P. | Vice President of Product Development |
Ms. Amy Goodowitz Levin B.S.N., R.N. | Vice President of Clinical Operations |
Mr. Jared Kelly J.D., L.L.M. | CEO & Director |
Jon Patton | Director of Investor Relations & Communication |
Mr. Andrew P. Aromando | Chief Business Officer |
Oncolytics Biotech Inc share price today is $1.01 as on at the close of the market. Oncolytics Biotech Inc share today touched a day high of $1.03 and a low of $0.95.
Oncolytics Biotech Inc share touched a 52 week high of $1.51 on and a 52 week low of $0.33 on . Oncolytics Biotech Inc stock price today i.e. is closed at $1.01,which is 33.11% down from its 52 week high and 210.01% up from its 52 week low.
Oncolytics Biotech Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Oncolytics Biotech Inc (ONCY) shares with as little as ₹88.615 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.15 in Oncolytics Biotech Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Oncolytics Biotech Inc share’s latest price of $1.01 as on November 6, 2025 at 2:29 am IST, you will get 9.9010 shares of Oncolytics Biotech Inc. Learn more about
fractional shares .
Oncolytics Biotech Inc stock has given -56.73% share price returns and 20.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?